The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022

Name: The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022 - MeduStudent
Price: 50.00 USD
Availability: InStock

$50,00

Samples for Courses Can be found here : Free Samples Here!

The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022

Categories: INTERNAL MEDICINE, PATHOLOGY

Description

The Brigham and Dana-Farber Board Review and Comprehensive Update in Hematology and Oncology 2022

Topics/Speakers

Molecular Genetics of Cancer – Nikhil Wagle, MD
Advances in Cancer Drug Development Part I – Chemotherapy and Targeted Agents – Geoffrey I. Shapiro, MD, PhD
Advances in Cancer Drug Development Part II – Modulation of the Tumor Microenvironment – Geoffrey I. Shapiro, MD, PhD
Infections in Cancer Patients – Lindsey Baden, MD
Symptom Management in Patients with Cancer – Andrew J. Lawton, MD
Communication: The Key to Excellence in End-of-Life Care – Rachelle E. Bernacki, MD
Biology of Hematopoietic Stem Cell Transplantation – Robert J. Soiffer, MD
Biology of Acute Leukemia and Myelodysplastic Syndromes – Benjamin L. Ebert, MD, PhD
Acute Leukemias – Daniel J. DeAngelo, MD, PhD
Myelodysplastic Syndrome – Eric S. Winer, MD
Chronic Myelogenous Leukemia – Marlise R. Luskin, MD
Myeloproliferative Syndromes – Ann M. Mullally, MD
Multiple Myeloma – Kenneth C. Anderson, MD
Waldenstrom Macroglobulemia and Amyloidosis – Jorge Castillo, MD
Low Grade Lymphomas – Caron A. Jacobson, MD
Aggressive Non-Hodgkin Lymphoma – Eric Jacobsen, MD
Hodgkin’s Lymphoma – Reid W. Merryman, MD
Diagnosis and Treatment of CLL and Related B Cell Malignancies – Matthew S. Davids, MD
Head and Neck Cancer – Robert I. Haddad, MD
Natural History, Screening, and Small Cell Lung Cancer – Bruce E. Johnson, MD
Non Small Cell Lung Cancer – Part 1 – Mark Awad, MD, PhD
Non Small Cell Lung Cancer – Part 2 – Mark Awad, MD, PhD
Mesothelioma and Thymoma – David M. Jackman, MD
Carcinoid and Neuroendocrine Tumors – Jennifer Ang Chan, MD
Novel Approaches for the Management of Esophageal and Gastric Cancers – Peter C. Enzinger, MD
Pancreatic Cancer – Brian M. Wolpin, MD
Hepatobiliary Cancer – James M. Cleary, MD, PhD
Anal Cancer & Colorectal Cancers Part 1 – Robert J. Mayer, MD
Colorectal Cancers Part 2 – Robert J. Mayer, MD
Gastrointestinal Cancer: Genetic Syndromes – Matthew Yurgelun, MD
Testicular Cancer – Mark M. Pomerantz, MD
Renal and Bladder Cancer – Guru P. Sonpavde, MBBS
Prostate Cancer Part I: Overview and Management of Localized Disease – Atish Choudhury, MD, PhD
Prostate Cancer Part II: Management of Disseminated Prostate Cancer – Atish Choudhury, MD, PhD
Melanoma – F. Stephen Hodi, MD
Sarcomas and Gastrointestinal Stromal Tumors (GIST) – Suzanne George, MD
Molecular Advances and Emerging Treatment Strategies in Ovarian Cancer – Ursula A. Matulonis, MD
Cervical and Endometrial Cancer – Panagiotis A. Konstantinopoulos, MD, PhD
Neuro-oncology – David A. Reardon, MD
Breast Cancer – Risk Factors, Genetics, Screening, and Prevention – Judy E. Garber, MD, MPH
Multimodality Therapy for Early Stage Breast Cancer: Part 1 – Surgery and Radiation – Harold J. Burstein, MD, PhD
Multimodality Therapy for Early Stage Breast Cancer: Part 2 – Systemic Therapy – Harold J. Burstein, MD, PhD
Management of Metastatic Breast Cancer – Adrienne G. Waks, MD
Breast Cancer Survivorship – Ann H. Partridge, MD, MPH
Hematopoiesis and Cytokines – David T. Scadden, MD
Acquired Bone Marrow Failure – Julie-Aurore Losman, MD, PhD
Congenital Bone Marrow Failure – Akiko Shimamura, MD, PhD
Hemophagocytic Syndromes and Related Immunodeficiencies – Barbara A. Degar, MD
Anemia – An Overview – Robert Stern, MD
Iron Deficiency and Iron Overload – Mark D. Fleming, MD, Dphil
Immune Hemolytic Anemia – Richard M. Kaufman, MD
Non-immune Hemolytic Anemia – David E. Golan, PhD, MD
Sickle Cell Disease – Maureen M. Achebe, MD, MPH
Thalassemia and Other Hemoglobinopathies – Matthew M. Heeney, MD
Disorders of Neutrophils – Nancy Berliner, MD
Acquired Thrombocytopenias – Elisabeth M. Battinelli, MD, PhD
Hemophilia – Aric D. Parnes, MD
Von Willebrand Disease and Congenital Platelet Disorders – Nathan T. Connell, MD, MPH
Congenital and Acquired Thrombophilia – Kenneth A. Bauer, MD
Use of Direct Oral Anticoagulants in Clinical Practice – Jean M. Connors, MD
Transfusion Medicine for the Clinician – Walter H. Dzik, MD